Omnicare (OCR) 10% Higher After ValueAct's Ubben Joins Board
More News related to OCR
- Omnicare to Present at the Credit Suisse 18th Annual Healthcare Conference
- Omnicare (OCR) Posts Q3 EPS of $0.60, In-Line with Views
- Omnicare Reports Third-Quarter Results
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
- Recovering Addict-Businessman Helps Government Recover Millions from Omnicare for Nursing Home Kickback Scheme
More News related to Corporate News
- Adams Resources & Energy (AE) Announces Activity At Haynesville Shale
- NCI Building Systems (NCS) Announces Put Option Notification for 2.125% Convertible Senior Subordinated Notes
- Novartis (NVS) Acquires Majority Stake in Zhejiang Tianyuan Bio-Pharmaceutical for $125 Million
- Ford (F) Gets $2.81B in Net Proceeds from Notes Offering
- Fed says fewer banks reported tightening credit in Q3
Shares of Omnicare, Inc. (NYSE: OCR) are 10% higher today after the company named Jeffrey W. Ubben, chief investment officer and a founder of ValueAct Capital, to its Board of Directors.
ValueAct Capital has entered into a standstill agreement with the Company.
ValueAct Capital currently owns approximately 9.68% of the Company's outstanding shares.
Related Categories
Corporate NewsInsiders' Blog
Stocks Mentioned
+0.62Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
